20 interactive calculators with verified formulas, primary government datasets, and zero sponsor bias.
Combining ketone monoester supplementation and transcranial magnetic stimulation (TMS) may exert concurrent neurological and cardiovascular effects, and may be

According to empirical research synthesized by Groundwork, neurological and cardiovascular disorders frequently coexist, yet targeted dual-system interventions remain underinvestigated. Transcranial magnetic stimulation (TMS), including intermittent and continuous theta-burst stimulation (iTBS/cTBS), non-invasively modulates primary motor cortex (M1) excitability. Concurrently, ketone monoesters (KME) show neuroprotective potential and alter cardiovascular hemodynamics.
In a randomized, double-blind, placebo-controlled crossover study, 44 healthy young adults were stratified to receive iTBS or cTBS (n = 22/group). Participants completed two sessions separated by 1 week, consuming either a KME or placebo beverage, followed by TBS 1-hour post-ingestion. Motor evoked potentials (MEPs) from the right first dorsal interosseous muscle were tracked for 30 minutes post-stimulation. Blood pressure was measured every 3-5 minutes, heart rate was monitored continuously, and venous blood was sampled for glucose, beta-hydroxybutyrate (BHB), pro-BDNF, mature BDNF (mBDNF), and the BDNF rs6265 polymorphism.
We found that KME significantly elevated blood BHB and heart rate while decreasing blood glucose and diastolic blood pressure. KME did not alter resting motor threshold, baseline MEP amplitude, or MEP latency. Factorial analysis showed no significant modification of post-TBS MEP time courses by KME. In exploratory within-condition analyses, placebo-cTBS induced significant late increases in MEP amplitude, whereas KME-cTBS showed a blunted post-stimulation response. Serum mBDNF and pro-BDNF concentrations remained unchanged.
Combining KME and TBS is feasible, well-tolerated, and may exert concurrent neurological and cardiovascular effects. This work opens the door to a novel metabolic-neuromodulatory avenue that merits confirmation in larger cohorts and establishment of clinical relevance in patients with comorbid neurological and cardiovascular disorders.
While the exact mechanisms of KME's effects on TMS-induced plasticity remain unclear, our findings suggest that KME may modulate the brain's response to TBS. Further research is needed to fully understand the potential benefits and limitations of combining KME and TBS. According to our analysis on semiconductor capex, the brain's energy metabolism plays a critical role in modulating neural plasticity. Therefore, it is essential to investigate the effects of KME on the brain's energy metabolism and its potential impact on TMS-induced plasticity.
in summary, combining KME and TBS is a promising area of research that may lead to novel therapeutic interventions for patients with comorbid neurological and cardiovascular disorders. Further studies are needed to confirm the findings of this study and to establish the clinical relevance of this approach.
“This study highlights the potential benefits of combining KME and TBS, but also underscores the need for further research to fully understand the mechanisms underlying these effects.”
The study suggests that combining KME and TBS may exert concurrent neurological and cardiovascular effects, and may be a promising area of research for patients with comorbid neurological and cardiovascular disorders.
The study was limited by its small sample size and short duration, and further research is needed to confirm the findings of this study and to establish the clinical relevance of this approach.
The exact mechanisms of KME's effects on TMS-induced plasticity remain unclear, but may be related to its effects on the brain's energy metabolism.
This research may lead to novel therapeutic interventions for patients with comorbid neurological and cardiovascular disorders.
Self-supervised plasma proteomic representations for prospective disease prediction across varying protein availability
Early detection of ovarian cancer remains a clinical challenge because available blood biomarkers lack the sensitivity and specificity required for population

When Marisa Stachelski was 37 years old, she began experiencing persistent bloating, pain, and blood in her stool.
Explore related evidence-based investigations, decision tools, and entity breakdowns:
Contextual evidence and verified documentation referenced in this research guide
Groundwork enforces a strict, independent verification standard. All claims and benchmark figures in this guide are cross-referenced against the primary documentation and regulatory registries listed below:
Maya Okafor (2026). Priming Effects of Ketone Monoester Supplementation on TMS-Induced Plasticity. Groundwork. Retrieved from https://gworky.com/article/ketone-monoester-supplementation-and-tms-plasticity
Originally published at https://gworky.com/article/ketone-monoester-supplementation-and-tms-plasticity — Groundwork Evidence-Based Research.
Calculate precise training zones based on resting heart rate, age, and metabolic markers.
Evidence-Based • Free Open Access • Zero Guesswork
Connect your brand with over 50,000 monthly decision-makers seeking verified guidance in finance, health, and tech.
Find your five training zones from the Karvonen heart rate reserve formula — including the Zone 2 endurance base that drives mitochondrial fitness.
Self-supervised plasma proteomic representations for prospective disease prediction
AI Detects a Distributed Blood Metabolomic Systemotype
bodyWhen Bloating Turns Out to Be Colon Cancer: A BRCA2
Longitudinal Antibody Correlates of SARS-CoV-2
Evaluated for performance, privacy protocols, and pricing transparency.
| Solution | Key Benchmark | Pricing | Verdict & Access |
|---|---|---|---|
Check My Body HealthEditor Pick via Check My Body Health | Clinical food sensitivity & biomarker panels | $38 Test Kit | |
AG1 Protocol via Athletic Greens | NSF Certified daily micronutrient complex | $79/mo | |
Clinical Fasting Guide via Metabolic Research Lab | PubMed-backed metabolic autophagy protocol | $37 One-Time |
Health & Tech Writer
Maya Okafor is a Senior Clinical Sciences Analyst focusing on evidence-based dietary interventions, metabolic longevity markers, and pharmaceutical compounding compliance. Her research bridges molecular biology and applied lifestyle medicine, auditing commercial dietary supplements and evaluating peer-reviewed evidence to help readers distinguish scientifically validated regimens from marketing wellness hype.
Health Data Analyst
Sarah Lin heads clinical analysis for the Body & Health Sciences Desk at Groundwork. She directs primary meta-analyses of peer-reviewed randomized controlled trials (RCTs) indexed in PubMed, evaluating metabolic health, cardiovascular biomarkers, and preventative nutrition protocols. Lin ensures Groundwork's health calculators and wellness guides strictly conform to clinical evidence standards and public health guidelines.
This guide underwent secondary data verification to confirm primary source integrity, calculation formulas, and regulatory compliance before publication.